Cargando…
The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition
PURPOSE: We present the English version of The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. METHODS: The JBCS formed a task force to update the JBCS Clinical Practice Guidelines, 2015 edition, according to Minds Handbook fo...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062371/ https://www.ncbi.nlm.nih.gov/pubmed/32240526 http://dx.doi.org/10.1007/s12282-020-01085-0 |
_version_ | 1783681748849131520 |
---|---|
author | Shimoi, Tatsunori Nagai, Shigenori E. Yoshinami, Tetsuhiro Takahashi, Masato Arioka, Hitoshi Ishihara, Mikiya Kikawa, Yuichiro Koizumi, Kei Kondo, Naoto Sagara, Yasuaki Takada, Masahiro Takano, Toshimi Tsurutani, Junji Naito, Yoichi Nakamura, Rikiya Hattori, Masaya Hara, Fimikata Hayashi, Naoki Mizuno, Toshiro Miyashita, Minoru Yamashita, Nami Yamanaka, Takashi Saji, Shigehira Iwata, Hiroji Toyama, Tatsuya |
author_facet | Shimoi, Tatsunori Nagai, Shigenori E. Yoshinami, Tetsuhiro Takahashi, Masato Arioka, Hitoshi Ishihara, Mikiya Kikawa, Yuichiro Koizumi, Kei Kondo, Naoto Sagara, Yasuaki Takada, Masahiro Takano, Toshimi Tsurutani, Junji Naito, Yoichi Nakamura, Rikiya Hattori, Masaya Hara, Fimikata Hayashi, Naoki Mizuno, Toshiro Miyashita, Minoru Yamashita, Nami Yamanaka, Takashi Saji, Shigehira Iwata, Hiroji Toyama, Tatsuya |
author_sort | Shimoi, Tatsunori |
collection | PubMed |
description | PURPOSE: We present the English version of The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. METHODS: The JBCS formed a task force to update the JBCS Clinical Practice Guidelines, 2015 edition, according to Minds Handbook for Clinical Practice Guideline Development 2014. First, we set multiple outcomes for each clinical question (CQ). Next, quantitative or qualitative systematic review was conducted for each of the multiple outcomes, and the strength of recommendation for the CQ was taken into consideration during meetings, with the aim of finding a balance between benefit and harm. Finalized recommendations from each session were confirmed through discussion and voting at the recommendation decision meeting. RESULTS: The recommendations, the strength of recommendation and the strength of evidence were determined based on systemic literature reviews and the meta-analyses for each CQ. CONCLUSION: The JBCS updated the Clinical Practice Guidelines for systemic treatment of breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12282-020-01085-0) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8062371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-80623712021-05-05 The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition Shimoi, Tatsunori Nagai, Shigenori E. Yoshinami, Tetsuhiro Takahashi, Masato Arioka, Hitoshi Ishihara, Mikiya Kikawa, Yuichiro Koizumi, Kei Kondo, Naoto Sagara, Yasuaki Takada, Masahiro Takano, Toshimi Tsurutani, Junji Naito, Yoichi Nakamura, Rikiya Hattori, Masaya Hara, Fimikata Hayashi, Naoki Mizuno, Toshiro Miyashita, Minoru Yamashita, Nami Yamanaka, Takashi Saji, Shigehira Iwata, Hiroji Toyama, Tatsuya Breast Cancer Special Article PURPOSE: We present the English version of The Japanese Breast Cancer Society (JBCS) Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition. METHODS: The JBCS formed a task force to update the JBCS Clinical Practice Guidelines, 2015 edition, according to Minds Handbook for Clinical Practice Guideline Development 2014. First, we set multiple outcomes for each clinical question (CQ). Next, quantitative or qualitative systematic review was conducted for each of the multiple outcomes, and the strength of recommendation for the CQ was taken into consideration during meetings, with the aim of finding a balance between benefit and harm. Finalized recommendations from each session were confirmed through discussion and voting at the recommendation decision meeting. RESULTS: The recommendations, the strength of recommendation and the strength of evidence were determined based on systemic literature reviews and the meta-analyses for each CQ. CONCLUSION: The JBCS updated the Clinical Practice Guidelines for systemic treatment of breast cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s12282-020-01085-0) contains supplementary material, which is available to authorized users. Springer Singapore 2020-04-02 2020 /pmc/articles/PMC8062371/ /pubmed/32240526 http://dx.doi.org/10.1007/s12282-020-01085-0 Text en © The Author(s) 2020, corrected publication 2021 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Special Article Shimoi, Tatsunori Nagai, Shigenori E. Yoshinami, Tetsuhiro Takahashi, Masato Arioka, Hitoshi Ishihara, Mikiya Kikawa, Yuichiro Koizumi, Kei Kondo, Naoto Sagara, Yasuaki Takada, Masahiro Takano, Toshimi Tsurutani, Junji Naito, Yoichi Nakamura, Rikiya Hattori, Masaya Hara, Fimikata Hayashi, Naoki Mizuno, Toshiro Miyashita, Minoru Yamashita, Nami Yamanaka, Takashi Saji, Shigehira Iwata, Hiroji Toyama, Tatsuya The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition |
title | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition |
title_full | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition |
title_fullStr | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition |
title_full_unstemmed | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition |
title_short | The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition |
title_sort | japanese breast cancer society clinical practice guidelines for systemic treatment of breast cancer, 2018 edition |
topic | Special Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062371/ https://www.ncbi.nlm.nih.gov/pubmed/32240526 http://dx.doi.org/10.1007/s12282-020-01085-0 |
work_keys_str_mv | AT shimoitatsunori thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT nagaishigenorie thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT yoshinamitetsuhiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT takahashimasato thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT ariokahitoshi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT ishiharamikiya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT kikawayuichiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT koizumikei thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT kondonaoto thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT sagarayasuaki thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT takadamasahiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT takanotoshimi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT tsurutanijunji thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT naitoyoichi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT nakamurarikiya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT hattorimasaya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT harafimikata thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT hayashinaoki thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT mizunotoshiro thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT miyashitaminoru thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT yamashitanami thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT yamanakatakashi thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT sajishigehira thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT iwatahiroji thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT toyamatatsuya thejapanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT shimoitatsunori japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT nagaishigenorie japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT yoshinamitetsuhiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT takahashimasato japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT ariokahitoshi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT ishiharamikiya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT kikawayuichiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT koizumikei japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT kondonaoto japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT sagarayasuaki japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT takadamasahiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT takanotoshimi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT tsurutanijunji japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT naitoyoichi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT nakamurarikiya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT hattorimasaya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT harafimikata japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT hayashinaoki japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT mizunotoshiro japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT miyashitaminoru japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT yamashitanami japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT yamanakatakashi japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT sajishigehira japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT iwatahiroji japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition AT toyamatatsuya japanesebreastcancersocietyclinicalpracticeguidelinesforsystemictreatmentofbreastcancer2018edition |